Chiral N-Triflyl Phosphoramides

Catalog No. Name CAS Inquiry
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3a'R,8a'R)-4',4',8',8'-tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetra-2-naphthalenyl-6-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetra-9-phenanthrenel-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxytetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-(3a'S8a'S)-4',4',8',8'-tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-3,7-bis(3,5-ditrifuloromethylphenyl)-5-oxidodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide
1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-3,7-di-9-anthracenyl-5-oxido-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide
Chiral Technical Information
Chiral Resolution Techniques by High Performance Liquid Chromatography (HPLC)
Chiral Resolution Techniques by High Performance Liquid Chromatography (HPLC)
Chiral Drugs and Intermediate Resolution Technologies
Chiral Drugs and Intermediate Resolution Technologies
Determination Techniques for Absolute Configuration of Chiral Compounds
Determination Techniques for Absolute Configuration of Chiral Compounds
Mechanism of Liquid Chromatographic Resolution of Chiral Compounds
Mechanism of Liquid Chromatographic Resolution of Chiral Compounds
Services
Our Services
Our Services

BOC Sciences leverages our expertise in asymmetric synthesis, chiral resolution and chiral analysis to support your research in chemical synthesis, drug development and analytical evaluation.

Learn More
Chiral Compounds
Our Products
Our Products

BOC Sciences delivers our global customers with more than 3,000 chiral chemicals and leading services, including chiral auxiliaries, chiral resolution reagents, chiral catalysts and chiral ligands.

Learn More
Support Information
Support Information

Please click here to learn more about chiral technical support.

Learn More
Our Features

Suitable for your research and production needs. BOC Sciences provides the most comprehensive products and services. 24 hours customer support!

24 h
100%
Best
Global
Navigation
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.